Ouch! Bigg Boss winner Pratham bites co-star Bhuvan’s thigh

coastaldigest.com news network
July 24, 2017

Bengaluru, Jul 24: Kannada television industry’s controversy-monger star Pratham has created a new history by allegedly biting his co-star Bhuvan Ponnanna during a physical fight between the two.

pratham

The incident took place last weekend when the cast and crew of the TV serial Sanju Mattu Naanu were packing up after finishing shooting.

In a complaint Bhuvan stated that Pratham picked up a fight with him over a silly issue and the fight ended up with the latter biting former’s thigh.

Sources from the set say that both Bhuvan and Pratham didn’t exactly share a rosy relationship even when the serial went on floors. The duo have had a difference of opinion on many occasions, some which even made it to the headlines.

“We don’t exactly know what transpired between them, but the talk is that Pratham made a few lowly remarks about actress Sanjana after she refused to hold his hand for a scene. The disparaging comments he made were apparently about Sanjana and Bhuvan. Bhuvan made a few sharp observations and tried to put Pratham in his place and that’s when the fight took an ugly turn,” says a source from the set who adds that there were many folks who witnessed these proceedings.

After having punched Pratham a few times, Bhuvan then proceeded to get medical treatment at a neighbouring hospital.

Pratham, the winner of the Bigg Boss Kannada season 4, had hit the headlines of all electronic media for attempting suicide. Bhuvan was also a participant in the Bigg Boss and the two didn’t see eye-to-eye.

Comments

SYED
 - 
Tuesday, 25 Jul 2017

ha...well done mrs speaker for expelling six congress mp's. what about the killers who killed muslims and dalits in the name of gou rakshak? you expelled immediately for just misbehavior and for the mob lynchers you set them freely. what a shame of this govt....kachada party bjp.

Jabbu
 - 
Tuesday, 25 Jul 2017

Pray for our weapons, not only pay if gauraks start same in DK we have to resist and we have to kill one of them ,that is only now way of our protect

Abdullah
 - 
Tuesday, 25 Jul 2017

She came home At 4.45.
Whole night where she has been???!!

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 26,2020

New Delhi, Feb 26: The death toll in northeast Delhi communal violence over the amended citizenship law rose to 20 on Wednesday, according to GTB Hospital authorities.

On Tuesday, the death toll was 13.

"The death toll has risen to 20 today," Medical Superintendent of GTB Hospital, Sunil Kumar, told PTI.

Earlier, at least four bodies were brought to the Guru Teg Bahadur Hospital from the Lok Nayak Jai Prakash Narayan Hospital, a senior official said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 25,2020

Bengaluru, Feb 25: In the view of 2nd PUC exams from March 4, the Bangalore Metropolitan Transport Corporation (BMTC) has approved free travel for students from home to exam centre on Monday.

"BMTC has extended free travel facility to all PUC students from their residence to examination centre on production of exam hall/admission ticket," said a press note.

BMTC has been issuing student concessional passes to travel from their residence to college at concessional rates for the benefit of students. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.